Brandie Morgan-Jack
09-06-23
For more information, please visit my website.
Read More
Rebecca Whiting
09-11-19
Ex vivo gene therapy for treatment of CLN2 Batten disease using a canine model. We are pursuing combined treatment of the brain and retina to achieve amelioration of all neurologic symptoms in this disease. To learn more about my lab, click here.
Read More
Lixing Reneker
09-11-19
Signal transduction pathways in lens development; Factors controlling corneal endothelial cell formation and differentiation. To learn more about my lab, click here.
Read More
Michael J. Petris
09-11-19
There is evidence that redox active metals such as copper contribute to Alzheimer’s disease. We are interested in characterizing how changes in metal ion homeostasis contribute to Alzheimer’s disease with an emphasis on inflammation. To learn more about my lab, click here.
Read More
Martin L Katz
09-11-19
The focus of my current research is on development of therapies for neurodegenerative disorders, with particular emphasis on the hereditary neuronal ceroid-lipofusconoses (NCLs) and amyotrophic lateral sclerosis (ALS). To learn more about my lab, click here.
Read More
Hu Huang
09-11-19
Dr. Hu Huang’s primary focus involves the study of the retina (a metabolically active tissue that senses light). Dysregulation of metabolism results in retinal cell dysfunction and miscommunication, subsequent cell death and vision loss.
Read More
